Expert Opinion on Drug Metabolism & Toxicology (EODMT)

Expert Opinion on Drug Metabolism & Toxicology [ISSN 1742-5255]; [e-ISSN 1744-7607] is a MEDLINE-indexed, international subscription-based journal publishing rigorously peer-reviewed review articles and original papers on all aspects of ADME-Tox. Each article is structured to incorporate the author’s own expert opinion on the impact of the topic on research and clinical practice and the scope for future development. Expert Opinion on Drug Metabolism & Toxicology addresses the needs of scientists and managers in the pharmaceutical industry, pharmacologists, clinical toxicologists and related professionals. The Editors welcome: Reviews covering: metabolic, pharmacokinetic and toxicological issues relating to specific drugs, drug-drug interactions, drug classes or their use in specific populations; issues relating to enzymes involved in the metabolism, disposition and excretion of drugs; techniques involved in the study of drug metabolism and toxicology; novel technologies for obtaining ADME-Tox data. Drug Evaluations reviewing the clinical, toxicological and pharmacokinetic data on a particular drug.

Expert Opinion on Drug Metabolism & Toxicology (EODMT) is :-

• International, Peer-Reviewed, Open Access, Refereed, metabolic, pharmacokinetic, the pharmaceutical industry, pharmacologists, clinical toxicologists, novel technologies, the metabolism, disposition , Online or Print , Monthly Journal

• UGC Approved, ISSN Approved: P-ISSN P-ISSN: 1742-5255, E-ISSN: 1744-7607, Established: 2005, Impact Factor: 3.9
• Provides Crossref DOI

• Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE